Pharmaceutical

University of Birmingham identifies target to reduce GV...

University of Birmingham researchers have identified CD70 as a key target to red...

UK Government to launch first ever men’s health strategy

The government said that men are less likely than women to seek medical help, pa...

UK reports near eradication of meningitis C amid declin...

Meningitis C cases are down 99% since the NHS routine vaccination programme was ...

Kronos Bio announces interim CEO and workforce cuts of 83%

Kronos Bio has announced the appointment of Deborah Knobelman as president and i...

Trump agency nominations show pharma industry as divide...

Confirmation of Trump's nominations for appointments is not yet assured and the ...

Health Canada approves Novo Nordisk’s Wegovy to cut hea...

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to redu...

Combatting Infectious Disease: Challenges and Opportuni...

The relationship between climate change and infectious disease is raising new qu...

CervoMed’s stock rises as FDA grants orphan drug status...

There are currently no FDA- or EMA-approved treatment options available for any ...

Wait for galactosemia therapy goes on after FDA shuns A...

The US Food and Drug Administration has declined to approve Applied Therapeutics...

Allink Biotherapeutics secures funding to advance ADC p...

Allink Biotherapeutics has completed a $42m Series A financing round to expedite...

Formosa and Medvisis agree on post-operative eye pain t...

Formosa has signed an exclusive licensing agreement with Medvisis for APP13007 f...

Trump 2.0 spells global change in pharmaceutical regula...

Trump's controversial administration nominees signal global ramifications for dr...

Advanz Pharma’s liver disease drug pulled from European...

This latest update comes after Advanz secured a suspension of the European Commi...

NHS rolls out monoclonal antibody treatment for rare bo...

The NHS will provide the monoclonal antibody Crysvita at 20 specialist centres a...

Eton acquires US rights to neonatal diabetes treatment ...

Eton has acquired the rights in the US to Amglidia for neonatal diabetes mellitu...

Roche’s tiragolumab flops in another Phase III lung can...

Tiragolumab missed the chance to prove a survival benefit in SKYSCRAPER-01 addin...